Trypanosoma cruzi in Los Angeles and Miami blood donors: impact of evolving donor demographics on seroprevalence and implications for transfusion transmission - PubMed (original) (raw)
Comparative Study
Trypanosoma cruzi in Los Angeles and Miami blood donors: impact of evolving donor demographics on seroprevalence and implications for transfusion transmission
David A Leiby et al. Transfusion. 2002 May.
Abstract
Background: Trypanosoma cruzi, the agent of Chagas' disease, continues to be a concern for blood safety, as demonstrated by recent transfusion-transmitted cases in the United States and Canada. The chronic nature of Chagas', coupled with increasing numbers of immigrants from T. cruzi-endemic countries, suggests that Chagas' is a long-term public health problem. Herein, we report on a multiyear epidemiologic study of T. cruzi in Los Angeles and Miami blood donors.
Study design and methods: From May 1994 to September 1998, blood donors in Los Angeles and Miami were queried regarding birth or time spent in an endemic country. Donations of "yes" respondents were tested by EIA, confirmed by radioimmunoprecipitation assay, and if confirmed as seropositive, enrolled in look-back investigations.
Results: A total of 1,104,030 Los Angeles and 181,139 Miami donors were queried regarding risk; 7.3 and 14.3 percent, respectively, responded yes. Seropositive rates were 1 in 7,500 Los Angeles and 1 in 9,000 Miami donors. In Los Angeles, seroprevalence rates increased significantly from 1996 to 1998 and were significantly higher for directed donors than nondirected donors. Look back identified 18 recipients, all of whom were seronegative for T. cruzi.
Conclusion: Significant numbers of T. cruzi-seropositive donors contribute to the U.S. blood supply. The incidence of seropositivity is enhanced by minority recruitment efforts necessitated by donor demographic shifts. Similarly, high rates among directed donations in Los Angeles are attributable to a disproportionate number of at-risk directed donors. Current look-back data likely underestimate the frequency of transfusion- transmitted T. cruzi. These results indicate that continued evaluation of transfusion as a mode of T. cruzi transmission in the United States is needed.
Similar articles
- Trypanosoma cruzi in a low- to moderate-risk blood donor population: seroprevalence and possible congenital transmission.
Leiby DA, Fucci MH, Stumpf RJ. Leiby DA, et al. Transfusion. 1999 Mar;39(3):310-5. doi: 10.1046/j.1537-2995.1999.39399219290.x. Transfusion. 1999. PMID: 10204596 - Seroepidemiology of Trypanosoma cruzi, etiologic agent of Chagas' disease, in US blood donors.
Leiby DA, Read EJ, Lenes BA, Yund AJ, Stumpf RJ, Kirchhoff LV, Dodd RY. Leiby DA, et al. J Infect Dis. 1997 Oct;176(4):1047-52. doi: 10.1086/516534. J Infect Dis. 1997. PMID: 9333165 - Specific antibodies to Trypanosoma cruzi among blood donors in Los Angeles, California.
Shulman IA, Appleman MD, Saxena S, Hiti AL, Kirchhoff LV. Shulman IA, et al. Transfusion. 1997 Jul;37(7):727-31. doi: 10.1046/j.1537-2995.1997.37797369449.x. Transfusion. 1997. PMID: 9225937 - [Chagas disease and blood transfusion: an emerging issue in non-endemic countries].
Assal A, Corbi C. Assal A, et al. Transfus Clin Biol. 2011 Apr;18(2):286-91. doi: 10.1016/j.tracli.2011.02.006. Epub 2011 Mar 26. Transfus Clin Biol. 2011. PMID: 21440479 Review. French. - Strategies for prevention of transfusion-associated Chagas' disease.
Moraes-Souza H, Bordin JO. Moraes-Souza H, et al. Transfus Med Rev. 1996 Jul;10(3):161-70. doi: 10.1016/s0887-7963(96)80057-5. Transfus Med Rev. 1996. PMID: 8809967 Review.
Cited by
- Clinical Characteristics and Outcomes of Chagas Disease in the United States: A Multicenter Retrospective Analysis.
Henao-Martínez AF, Olivo-Freites C, Higuita NIA, Ferraz C, Franco-Paredes C, Tuells J, Woc-Colburn L, Villalpando-Carrión S, Chastain DB, Rassi A. Henao-Martínez AF, et al. Am J Trop Med Hyg. 2023 Sep 11;109(5):1006-1011. doi: 10.4269/ajtmh.23-0361. Print 2023 Nov 1. Am J Trop Med Hyg. 2023. PMID: 37696508 Free PMC article. - Characterization of Latin American migrants at risk for Trypanosoma cruzi infection in a non-endemic setting. Insights into initial evaluation of cardiac and digestive involvement.
Laynez-Roldán P, Losada-Galván I, Posada E, de la Torre Ávila L, Casellas A, Sanz S, Subirà C, Rodriguez-Valero N, Camprubí-Ferrer D, Vera I, Roldán M, Aldasoro E, Oliveira-Souto I, Calvo-Cano A, Valls ME, Álvarez-Martínez MJ, Gállego M, Abras A, Ballart C, Muñoz J, Gascón J, Pinazo MJ. Laynez-Roldán P, et al. PLoS Negl Trop Dis. 2023 Jul 13;17(7):e0011330. doi: 10.1371/journal.pntd.0011330. eCollection 2023 Jul. PLoS Negl Trop Dis. 2023. PMID: 37440480 Free PMC article. - Advances in Protozoan Epigenetic Targets and Their Inhibitors for the Development of New Potential Drugs.
Gaona-López C, Vazquez-Jimenez LK, Gonzalez-Gonzalez A, Delgado-Maldonado T, Ortiz-Pérez E, Nogueda-Torres B, Moreno-Rodríguez A, Vázquez K, Saavedra E, Rivera G. Gaona-López C, et al. Pharmaceuticals (Basel). 2023 Apr 4;16(4):543. doi: 10.3390/ph16040543. Pharmaceuticals (Basel). 2023. PMID: 37111300 Free PMC article. Review. - Recognition and screening for Chagas disease in the USA.
Marcus R, Henao-Martínez AF, Nolan M, Livingston E, Klotz SA, Gilman RH, Miranda-Schaeubinger M, Meymandi S. Marcus R, et al. Ther Adv Infect Dis. 2021 Sep 22;8:20499361211046086. doi: 10.1177/20499361211046086. eCollection 2021 Jan-Dec. Ther Adv Infect Dis. 2021. PMID: 34589212 Free PMC article. Review. - Parasitic infections represent a significant health threat among recent immigrants in Chicago.
Herrick JA, Nordstrom M, Maloney P, Rodriguez M, Naceanceno K, Gallo G, Mejia R, Hershow R. Herrick JA, et al. Parasitol Res. 2020 Mar;119(3):1139-1148. doi: 10.1007/s00436-020-06608-4. Epub 2020 Feb 1. Parasitol Res. 2020. PMID: 32008064 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical